Brookie M. Best
Titel
Citeras av
Citeras av
År
Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system
S Letendre, J Marquie-Beck, E Capparelli, B Best, D Clifford, AC Collier, ...
Archives of neurology 65 (1), 65-70, 2008
8652008
Resistance to intravenous immunoglobulin in children with Kawasaki disease
AH Tremoulet, BM Best, S Song, S Wang, E Corinaldesi, JR Eichenfield, ...
The Journal of pediatrics 153 (1), 117-121. e3, 2008
3502008
Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy
M Goicoechea, S Liu, B Best, S Sun, S Jain, C Kemper, M Witt, ...
The Journal of infectious diseases 197 (1), 102-108, 2008
3342008
Recognition of a Kawasaki disease shock syndrome
JT Kanegaye, MS Wilder, D Molkara, JR Frazer, J Pancheri, AH Tremoulet, ...
Pediatrics 123 (5), e783-e789, 2009
3102009
Infliximab treatment of intravenous immunoglobulin–resistant Kawasaki disease
JC Burns, BM Best, A Mejias, L Mahony, DE Fixler, HS Jafri, ME Melish, ...
The Journal of pediatrics 153 (6), 833-838. e6, 2008
2982008
Reduced lopinavir exposure during pregnancy
AM Stek, M Mirochnick, E Capparelli, BM Best, C Hu, SK Burchett, C Elgie, ...
Aids 20 (15), 1931-1939, 2006
1922006
Low atazanavir concentrations in cerebrospinal fluid
BM Best, SL Letendre, E Brigid, DB Clifford, AC Collier, BB Gelman, ...
AIDS (London, England) 23 (1), 83, 2009
1332009
Randomized trial of central nervous system–targeted antiretrovirals for HIV-associated neurocognitive disorder
RJ Ellis, S Letendre, F Vaida, R Haubrich, RK Heaton, N Sacktor, ...
Clinical infectious diseases 58 (7), 1015-1022, 2014
1122014
Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries …
JD Hirsch, M Gonzales, A Rosenquist, TA Miller, TP Gilmer, BM Best
Journal of Managed Care Pharmacy 17 (3), 213-223, 2011
1072011
Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries
JD Hirsch, A Rosenquist, BM Best, TA Miller, TP Gilmer
Journal of Managed Care Pharmacy 15 (1), 32-41, 2009
892009
Lopinavir tablet pharmacokinetics with an increased dose during pregnancy
BM Best, AM Stek, M Mirochnick, C Hu, H Li, SK Burchett, SS Rossi, ...
Journal of acquired immune deficiency syndromes (1999) 54 (4), 381, 2010
872010
Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum
TR Cressey, A Stek, E Capparelli, C Bowonwatanuwong, S Prommas, ...
Journal of acquired immune deficiency syndromes (1999) 59 (3), 245, 2012
852012
Pharmacokinetics of lopinavir/ritonavir crushed versus whole tablets in children
BM Best, EV Capparelli, H Diep, SS Rossi, MJ Farrell, E Williams, G Lee, ...
Journal of acquired immune deficiency syndromes (1999) 58 (4), 385, 2011
852011
Low CSF concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir
BM Best, SL Letendre, P Koopmans, SS Rossi, DB Clifford, AC Collier, ...
Journal of acquired immune deficiency syndromes (1999) 59 (4), 376, 2012
822012
Atazanavir pharmacokinetics with and without tenofovir during pregnancy
M Mirochnick, BM Best, AM Stek, EV Capparelli, C Hu, SK Burchett, ...
Journal of acquired immune deficiency syndromes (1999) 56 (5), 412, 2011
822011
Efavirenz concentrations in CSF exceed IC50 for wild-type HIV
BM Best, PP Koopmans, SL Letendre, EV Capparelli, SS Rossi, ...
Journal of Antimicrobial Chemotherapy 66 (2), 354-357, 2011
822011
Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance
W Fury, AH Tremoulet, VE Watson, BM Best, C Shimizu, J Hamilton, ...
Human immunology 71 (9), 865-873, 2010
762010
Lopinavir exposure with an increased dose during pregnancy
M Mirochnick, BM Best, AM Stek, E Capparelli, C Hu, SK Burchett, ...
Journal of acquired immune deficiency syndromes (1999) 49 (5), 485, 2008
732008
Cardiovascular biomarkers in acute Kawasaki disease
YZ Sato, DP Molkara, LB Daniels, AH Tremoulet, C Shimizu, JT Kanegaye, ...
International journal of cardiology 164 (1), 58-63, 2013
722013
Incidence of Kawasaki disease in northern European countries
E Salo, EP Griffiths, T Farstad, B Schiller, Y Nakamura, M Yashiro, ...
Pediatrics International 54 (6), 770-772, 2012
722012
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20